Home -> Law Blog Directory -> Personal Injury Law Blogs -> Maryland Accident Law Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Maryland Accident Law BlogRoche Loses Drug Litigation Lawsuit and Is Ordered to Pay Almost $13 Million to Three Accutane Users
By Jack Lebowitz, Esq. and Vadim Mzhen, Esq.
A jury in the United States has ordered drug manufacturer Roche to pay $12.9 million to three Accutane users who say they developed chronic bowel disorders from using the popular acne drug. The jury determined that the Swiss drug maker failed to properly warn of the side effects that can result from using Accutane.
The patients began using Accutane more than 10 years ago when they were teenagers to treat their acne. As a result of using the acne drug, two of the patients say they now require long-term drug rehabilitation and the third patient has to have his colon removed.
This is not the first drug litigation lawsuit filed against Roche that links Accutane to inflammatory bowel disease. This is the fourth IBD civil trial the Swiss Drug maker has lost.
Inflammatory Bowel Disease
There are two kinds of chronic diseases that can cause inflammation to the intestines and result in ulcers:
? Crohn?s Disease
? Ulcerative Colitis
While the drug?s warning label says Accutane is ?associated with? chronic bowel problems, the drug maker maintains that there is no direct connection between chronic bowel ailments and Accutane. The drug litigation attorneys for the plaintiffs, however, say Roche has conducted internal studies that indicate Accutane can damage the intestinal tract and result in inflammatory bowel disease.
Hoffman-La Roche, Roche?s US subsidiary, plans to appeal the dangerous drug verdict. The company continues to maintain that there is no scientific evidence that proves using Accutane can cause IBD.
Accutane
Over 13 million people have used Accutane since 1982. Until the drug's patent expired six years ago, the acne medication was one of Roche?s top selling drugs. It is also a controversial drug.
Accutane was linked to birth defects in the 1980?s and 266 suicide cases in the US. It has also been associated with problems affecting the musculoskeletal, cardiovascular, and autoimmune systems, as well as the pancreas, liver, central nervous system, and kidneys. Some 500 lawsuits have been filed over the acne drug.
Roche Loses Fourth Accutane Trial, Ordered to Pay 3 IBD Victims, $12.9 Million, News Inferno, November 21, 2008
Pharma Roundup: Lawsuit for Roche, Teva Troubles for AstraZeneca, and More, BNET, November 19, 2008
Related Web Resources:
Accutane, Drugs.com
Inflammatory Bowel Disease, FamilyDoctor.org
Full post as published by Maryland Accident Law Blog on December 11, 2008 (boomark / email).
Mesothelioma Law Suit
Asbestos Exposure
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
Copyright Lawsuits: Critical Issues Before Filing Copyright
Federa Rule 11(b) Considerations
Vioxx Lawsuits
Vioxx personal injury suits are a seroius concern for Merck and patietns
Construction Site Accidents
Lawsuits related to accidents
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Social Security Loses Class Action, Will Pay $500 Million in Benefits
Social Security Loses Class Action, Will Pay $500 Million in Benefits
$189 Million Settlement Reached in Slab Litigation
$189 Million Settlement Reached in Slab Litigation
McKesson Corp.
$13.25 million settlement in lifestyle drug abuse lawsuit.
Drug Pusher
Biovail agrees to pay $24.6 million settlement in criminal lawsuit.
CellCept
Roche Issues Changes to Warnings and Adverse Events

Jury Awards $7 Million in Accutane Lawsuit
Appeals Court Upholds $7 Million Accutane Judgement against Roche Pharmaceuticals
Accutane Verdict of $10.6 Million
Attorney Peter Kaufman on Accutane Litigation
Warning of Risk is Unavailing to Drug Maker
Accutane News - Case 1, 2 and 3 - $7m, $2.6m and now $10.5m








